Subscribe to RSS
DOI: 10.1055/s-0043-1771465
Wilson's Disease
![](https://www.thieme-connect.de/media/sin/202304/lookinside/thumbnails/10-1055-s-0043-1771465_20230049-1.jpg)
Abstract
Wilson's disease (WD) can present with liver disease, neurological deficits, and psychiatric disorders. Results of genetic prevalence studies suggest that WD might be much more common than previously estimated. Early recognition of WD remains challenging because it is a great imitator and requires a high index of suspicion for correct and timely diagnosis. Early diagnosis of WD is crucial to ensure that patients can be started on adequate treatment. In association with other clinical and biochemical tests, liver biopsy results and molecular genetic testing can also be used for diagnosing WD. Medical therapy is effective for most patients; liver transplant can rescue those with acute liver failure or those with advanced liver disease who fail to respond to or discontinue medical therapy. Although novel therapies, such as gene therapy, are on the horizon, screening and prevention of delayed diagnosis remains paramount.
Publication History
Article published online:
22 August 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Wilson S. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912; 34 (04) 295-507
- 2 Sternlieb I, Scheinberg IH. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med 1968; 278 (07) 352-359
- 3 Scheinberg IH, Sternlieb I. Wilson's disease. In: Major Problems in Internal Medicine Series. Philadelphia: W. B. Saunders; 1984: 192
- 4 Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The prevalence of Wilson's disease: an update. Hepatology 2020; 71 (02) 722-732
- 5 Gitlin JD. Wilson disease. Gastroenterology 2003; 125 (06) 1868-1877
- 6 Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007; 369 (9559): 397-408
- 7 Sandahl TD, Gormsen LC, Kjaergaard K. et al. The pathophysiology of Wilson's disease visualized: a human 64 Cu PET study. Hepatology 2022; 75 (06) 1461-1470
- 8 Alt ER, Sternlieb I, Goldfischer S. The cytopathology of metal overload. Int Rev Exp Pathol 1990; 31: 165-188
- 9 Müller T, Langner C, Fuchsbichler A. et al. Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. Hepatology 2004; 39 (04) 963-969
- 10 Strand S, Hofmann WJ, Grambihler A. et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 1998; 4 (05) 588-593
- 11 Machado A, Chien HF, Deguti MM. et al. Neurological manifestations in Wilson's disease: report of 119 cases. Mov Disord 2006; 21 (12) 2192-2196
- 12 Pfeiffer RF. Wilson disease. Continuum (Minneap Minn) 2016; 22 (4 Movement Disorders): 1246-1261
- 13 Schilsky ML, Roberts EA, Bronstein JM. et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 practice guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology 2022; 0: 1-49
- 14 Wendon J, Cordoba J, Dhawan A. et al; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, Clinical practice guidelines panel, Panel members, EASL Governing Board representative. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017; 66 (05) 1047-1081
- 15 Ostapowicz G, Fontana RJ, Schiødt FV. et al; U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137 (12) 947-954
- 16 Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3: 282-298
- 17 Schilsky ML, Roberts EA, Bronstein JM. et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: executive summary of the 2022 practice guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology 2023; 77 (04) 1428-1455
- 18 Burke JF, Dayalu P, Nan B, Askari F, Brewer GJ, Lorincz MT. Prognostic significance of neurologic examination findings in Wilson disease. Parkinsonism Relat Disord 2011; 17 (07) 551-556
- 19 Członkowska A, Litwin T, Dzieżyc K, Karliński M, Bring J, Bjartmar C. Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson's Disease Rating Scale. BMC Neurol 2018; 18 (01) 34
- 20 Walshe JM, Yealland M. Wilson's disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry 1992; 55 (08) 692-696
- 21 Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007; 56 (01) 115-120
- 22 Hedera P. Wilson's disease: a master of disguise. Parkinsonism Relat Disord 2019; 59: 140-145
- 23 Pellecchia MT, Criscuolo C, Longo K, Campanella G, Filla A, Barone P. Clinical presentation and treatment of Wilson's disease: a single-centre experience. Eur Neurol 2003; 50 (01) 48-52
- 24 Starosta-Rubinstein S, Young AB, Kluin K. et al. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 1987; 44 (04) 365-370
- 25 Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol 1991; 238 (05) 281-287
- 26 Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115 (09) 720-726
- 27 Soltanzadeh A, Soltanzadeh P, Nafissi S, Ghorbani A, Sikaroodi H, Lotfi J. Wilson's disease: a great masquerader. Eur Neurol 2007; 57 (02) 80-85
- 28 Mura G, Zimbrean PC, Demelia L, Carta MG. Psychiatric comorbidity in Wilson's disease. Int Rev Psychiatry 2017; 29 (05) 445-462
- 29 Dening TR, Berrios GE. Wilson's disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry 1989; 46 (12) 1126-1134
- 30 Litwin T, Gromadzka G, Członkowska A. Gender differences in Wilson's disease. J Neurol Sci 2012; 312 (1-2): 31-35
- 31 Zimbrean PC, Schilsky ML. Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry 2014; 36 (01) 53-62
- 32 Kumar R, Datta S, Jayaseelan L, Gnanmuthu C, Kuruvilla K. The psychiatric aspects of Wilson's disease-a study from a neurology unit. Indian J Psychiatry 1996; 38 (04) 208-211
- 33 Lowette KF, Desmet K, Witters P. et al. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine. Eur J Gastroenterol Hepatol 2010; 22 (05) 564-571
- 34 Srinivas K, Sinha S, Taly AB. et al. Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!. J Neurol Sci 2008; 266 (1-2): 104-108
- 35 Prashanth LK, Taly AB, Sinha S, Arunodaya GR, Swamy HS. Wilson's disease: diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry 2004; 75 (06) 907-909
- 36 Lin LJ, Wang DX, Ding NN, Lin Y, Jin Y, Zheng CQ. Comprehensive analysis on clinical features of Wilson's disease: an experience over 28 years with 133 cases. Neurol Res 2014; 36 (02) 157-163
- 37 Frota NA, Barbosa ER, Porto CS. et al. Cognitive impairment and magnetic resonance imaging correlations in Wilson's disease. Acta Neurol Scand 2013; 127 (06) 391-398
- 38 Cochen De Cock V, Lacombe S, Woimant F, Poujois A. Sleep disorders in Wilson's disease. Sleep Med 2021; 83: 299-303
- 39 Tribl GG, Bor-Seng-Shu E, Trindade MC, Lucato LT, Teixeira MJ, Barbosa ER. Wilson's disease presenting as rapid eye movement sleep behavior disorder: a possible window to early treatment. Arq Neuropsiquiatr 2014; 72 (09) 653-658
- 40 Kłysz B, Bembenek J, Skowrońska M, Członkowska A, Kurkowska-Jastrzębska I. Autonomic nervous system dysfunction in Wilson's disease - a systematic literature review. Auton Neurosci 2021; 236: 102890
- 41 Meenakshi-Sundaram S, Taly AB, Kamath V, Arunodaya GR, Rao S, Swamy HS. Autonomic dysfunction in Wilson's disease –a clinical and electrophysiological study. Clin Auton Res 2002; 12 (03) 185-189
- 42 Chu EC, Chu NS, Huang CC. Autonomic involvement in Wilson's disease: a study of sympathetic skin response and RR interval variation. J Neurol Sci 1997; 149 (02) 131-137
- 43 Roberts EA, Schilsky ML. Division of Gastroenterology and Nutrition, Hospital for Sick Children, Toronto, Ontario, Canada. A practice guideline on Wilson disease. Hepatology 2003; 37 (06) 1475-1492
- 44 Quemeneur AS, Trocello JM, Ea HK. et al. Bone status and fractures in 85 adults with Wilson's disease. Osteoporos Int 2014; 25 (11) 2573-2580
- 45 Shah R, Amador C, Tormanen K. et al. Systemic diseases and the cornea. Exp Eye Res 2021; 204: 108455
- 46 Jang HJ, Kim JM, Choi CY. Elemental analysis of sunflower cataract in Wilson's disease: a study using scanning transmission electron microscopy and energy dispersive spectroscopy. Exp Eye Res 2014; 121: 58-65
- 47 Mezaki T, Matsumoto S, Hamada C. et al. Decreased serum ceruloplasmin and copper levels in cervical dystonia. Ann Neurol 2001; 49 (01) 138-139
- 48 Korman JD, Volenberg I, Balko J. et al; Pediatric and Adult Acute Liver Failure Study Groups. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008; 48 (04) 1167-1174
- 49 Tu JB, Blackwell RQ. Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease. Metabolism 1967; 16 (06) 507-513
- 50 Mounajjed T, Oxentenko AS, Qureshi H, Smyrk TC. Revisiting the topic of histochemically detectable copper in various liver diseases with special focus on venous outflow impairment. Am J Clin Pathol 2013; 139 (01) 79-86
- 51 EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 2012; 56 (03) 671-685
- 52 Saroli Palumbo C, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med 2019; 7 (Suppl. 02) S65
- 53 Ferenci P, Caca K, Loudianos G. et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003; 23 (03) 139-142
- 54 Scheinberg IH, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Engl J Med 1987; 317 (04) 209-213
- 55 Boga S, Jain D, Schilsky ML. Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature. BMC Pharmacol Toxicol 2015; 16: 30
- 56 Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson's disease: a review of what we have learned. World J Hepatol 2015; 7 (29) 2859-2870
- 57 Weiss KH, Schäfer M, Gotthardt DN. et al. Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease. Clin Transplant 2013; 27 (06) 914-922
- 58 Poujois A, Sobesky R, Meissner WG. et al. Liver transplantation as a rescue therapy for severe neurologic forms of Wilson disease. Neurology 2020; 94 (21) e2189-e2202
- 59 Allocca S, Ciano M, Ciardulli MC. et al. An αB-crystallin peptide rescues compartmentalization and trafficking response to Cu overload of ATP7B-H1069Q, the most frequent cause of Wilson disease in the Caucasian population. Int J Mol Sci 2018; 19 (07) 1892
- 60 Murillo O, Luqui DM, Gazquez C. et al. Long-term metabolic correction of Wilson's disease in a murine model by gene therapy. J Hepatol 2016; 64 (02) 419-426
- 61 Beinhardt S, Leiss W, Stättermayer AF. et al. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol 2014; 12 (04) 683-689
- 62 Dzieżyc K, Karliński M, Litwin T, Członkowska A. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients. Eur J Neurol 2014; 21 (02) 332-337
- 63 Schilsky ML, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991; 100 (03) 762-767
- 64 Akil M, Schwartz JA, Dutchak D, Yuzbasiyan-Gurkan V, Brewer GJ. The psychiatric presentations of Wilson's disease. J Neuropsychiatry Clin Neurosci 1991; 3 (04) 377-382